Annals of Oncology

In this issue:

In this issue
Ann Oncol 4: 259.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 4: 259.
[PDF] [Request Permissions]

News:

Numbers in paediatric oncology
Ann Oncol 4: 260.
[PDF] [Request Permissions]

European hematologists organize first congress
Ann Oncol 4: 260.
[PDF] [Request Permissions]

Brain cancer scare hits U.S. phone manufacturers
Ann Oncol 4: 260-261.
[PDF] [Request Permissions]

Debate over passive smoking hotter than ever
Ann Oncol 4: 261.
[PDF] [Request Permissions]

NIH a victim of partisan conflict?
Ann Oncol 4: 261.
[PDF] [Request Permissions]

Bart's to become a new cancer hospital?
Ann Oncol 4: 261.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 4: 261-262.
[PDF] [Request Permissions]

Editorial:

F. Cavalli

Towards a global cancer strategy
Ann Oncol 4: 263.
[PDF] [Request Permissions]

Birthe Lund

Ovarian cancer: Any progress?
Ann Oncol 4: 264-265.
[PDF] [Request Permissions]

Review:

F.De Conno, C. Ripamonti, A. Sbanotto, L. Saita, E. Zecca, and V. Ventafridda

The pharmacological management of cancer pain
Ann Oncol 4: 267-276.
[PDF] [Request Permissions]

Commentary:

G. J. Peters and Y. M. Rustum

Novel approaches to selective treatments of human solid tumors: Laboratory and clinical correlation: international symposioum held at the Rosewell Park Cnacer Institute, Buffalo, N.Y, U.S.A., Sept. 1992 (organized by Dr.Y.M. Rustum)
Ann Oncol 4: 277-282.
[PDF] [Request Permissions]

Arena:

J. S. Tobias and I. Mittra

Improving cancer care world wide
Ann Oncol 4: 283-287.
[PDF] [Request Permissions]

Original articles:

F. Levi, S. Franceschi, C. La Vecchia, J. Ruzicka, E. Gloor, and L. Randimbison

Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland
Ann Oncol 4: 289-294.
[Abstract] [PDF] [Request Permissions]

P. S. G. J. Hupperets, J. Wils, L. Volovics, L. Schouten, M. Fickers, H. Bron, H. C. Schouten, J. Jager, J. Smeets, J. de Jong, and G. H. Blijham

Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients
Ann Oncol 4: 295-301.
[Abstract] [PDF] [Request Permissions]

J. B. Vermorken, S. Gundersen, M. Clavel, J. F. Smyth, P. Dodion, J. Renard, S. B. Kaye, and For the EORTC Early Clinical Trials Group and the EORTC Data Center

Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer
Ann Oncol 4: 303-306.
[Abstract] [PDF] [Request Permissions]

P. Peltier, J.-P. Dutin, J.-F Chatal, P. Fumoleau, P. Bourguet, J.-C. Liehn, J.-P Vuillez, J.-Y Hérry, A. Loboguerrero, and the INSERM Research Network(Nantes, Rennes, Reims, Vuillejuif, Saclay)

Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC125) specific for CA125 antigen
Ann Oncol 4: 307-311.
[Abstract] [PDF] [Request Permissions]

C. Solá, J. Mallafré, L. Mendoza Solórzano, A. Segarra, M. Daniels, N. Vinolas, A. Alcaraz, M. Solé, R. Alvarez, A. Biete, and J. Estapé

Carboplatin, methotrexate, vinblastine and epirubicin (Carbo-MVE) for transitional cell bladder carcinoma
Ann Oncol 4: 313-316.
[Abstract] [PDF] [Request Permissions]

C. J. van Groeningen, G. J. Peters, and H. M. Pinedo

Reversal of 5-fluorouracil-induced toxicity by oral administration of uridine
Ann Oncol 4: 317-320.
[Abstract] [PDF] [Request Permissions]

E. Boven, E. Venema-Gaberscek, C. A. M. Erkelens, M. C. Bissery, and H. M. Pinedo

Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer
Ann Oncol 4: 321-324.
[Abstract] [PDF] [Request Permissions]

Book reviews:

Paul Workman

Book review
Ann Oncol 4: 301-302.
[PDF] [Request Permissions]

E. Zucca

Book review
Ann Oncol 4: 336.
[PDF] [Request Permissions]

F. Cavalli

Book review
Ann Oncol 4: 340.
[PDF] [Request Permissions]

Clinical case:

R. L. Souhami

Introduction to the Clinical Case Series
Ann Oncol 4: 325.
[PDF] [Request Permissions]

A. P. M. Lydon, S. J. Harland, and G. M. Duchesne

The management of bladder cancer —a case history
Ann Oncol 4: 325-329.
[PDF] [Request Permissions]

Short report:

W. C. Mertens, E. A. Eisenhauer, M. Moore, P. Venner, D. Stewart, A. Muldal, and D. Wong

Gemcitabine in advanced renal cell carcinoma: A phase II study of the National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 4: 331-332.
[Abstract] [PDF] [Request Permissions]

P. Rougier, J. J. Zarba, M. Ducreux, M. Basile, J. P. Pignon, M. Mahjoubi, M. Benahmed, J. P. Droz, E. Cvitkovic, and J. P. Armand

Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma
Ann Oncol 4: 333-336.
[Abstract] [PDF] [Request Permissions]

E. M. Rankin and J. F. Pitts

Ophthalmic toxicity during carboplatin therapy
Ann Oncol 4: 337-338.
[PDF] [Request Permissions]

Letter:

Letter to the editor: Relapse of acute myeloblastic leukaemia presenting as temporal bone chloroma with facial nerve paralysis
Ann Oncol 4: 339-340.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.